Notably, the loss of CHD5 occurred frequently in the genome, which affected the copy number of CHD5 in glioma (Loss = 56, Gain = 5), and was one of the reasons for the low expression of CHD5 in Glioma. Here, CHD5 is linked to central nervous system cancer.